Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus

NCT01294436 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

728

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes
High Blood Sugar

Interventions

DRUG: Dapagliflozin

Sponsor

AstraZeneca

Collaborators

[object Object]